OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

Historical Holders from Q3 2024 to Q3 2025

Symbol
OKUR on Nasdaq
Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Shares outstanding
12,856,017
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
10,219,418
Holdings value
$28,103,553
% of all portfolios
0%
Number of holders
41
Number of buys
15
Number of sells
-20
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACORN BIOVENTURES, L.P. 22.1% $7,099,185 2,839,674 Anders Hove 15 May 2025
Shay Capital LLC 6.3% $2,057,944 810,214 Shay Capital LLC 15 May 2025
Prosight Management, LP 5.8% $2,214,578 745,649 Prosight Management, LP 24 Nov 2025
VANGUARD GROUP INC 5.58% $1,795,102 706,733 The Vanguard Group 31 Dec 2024
CANTOR FITZGERALD & CO. 5.2% $1,606,894 669,539 Cantor Fitzgerald Securities 30 Jun 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 5.2% +67% $1,592,657 +$633,274 663,607 +66% Highbridge Capital Management, LLC 30 Jun 2025
Deep Track Capital, LP 4.14% $1,330,932 523,989 Deep Track Capital, LP 31 Dec 2024
Lundbeckfond Invest A/S 1.6% $515,930 203,122 Lundbeckfond Invest A/S 31 Dec 2024

Institutional Holders of OnKure Therapeutics, Inc. - Class A Common Stock, par value $0.0001 per share (OKUR)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 10,219,418 $28,103,553 -$1,295,979 $2.75 41
2025 Q2 10,778,865 $25,758,405 -$10,457,913 $2.39 48
2025 Q1 11,945,383 $50,147,392 -$1,567,896 $4.3 46
2024 Q4 11,839,453 $99,220,652 +$88,963,332 $8.6 50
2024 Q3 3,200 $5,440 +$5,440 $1.7 1